反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]([CH:14]3[CH2:18][CH2:17][CH2:16][N:15]3[CH3:19])[CH:11]=[N:12][CH:13]=2)=[CH:4][CH:3]=1.[C:20]([OH:27])(=[O:26])/[CH:21]=[CH:22]/[C:23]([OH:25])=[O:24]>CO>[C:20]([OH:27])(=[O:26])/[CH:21]=[CH:22]/[C:23]([OH:25])=[O:24].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:9]=[C:10]([CH:14]3[CH2:18][CH2:17][CH2:16][N:15]3[CH3:19])[CH:11]=[N:12][CH:13]=2)=[CH:6][CH:7]=1参加物
4
実験手順
The above-referenced pyridine was converted into invention compound of Formula I by the addition of one equivalent of fumaric acid to a methanol (15 mL) solution of the free amine at 25° C. After 30 minutes the solvent was removed in vacuo and the residue pumped under high vacuum. Trituration with diethyl ether followed by recrystallization from ethyl acetate afforded 5-(4-chlorophenyl)-3-(1-methyl-2-pyrrolidinyl)pyridine fumarate, (72%) as a colorless solid. M.p. 159°-160° C. (EtOAc); 1H NMR (DMSO-d6, 300 MHz): δ8.84 (d, J=3 Hz, 1H), 8.58 (d, J=3 Hz, 1H), 8.08 (t, J=2 Hz, 1H), 7.79 (d, J=8 Hz, 2H), 7.56 (d, J=8 Hz, 2H), 6.62 (s, 2H), 3.49 (t, J=6 Hz, 1H), 3.32 (m, 1H), 2.52 (m, 1H), 2.28 (m, 1H), 2.24 (s, 3H), 1.9 (m, 3H).
後処理
- customAfter 30 minutes the solvent was removed in vacuo
- customTrituration with diethyl ether followed by recrystallization from ethyl acetate
出典と根拠
- ORDレコード
- ord-8e292d135b104a7aa8f8944b9c14e638
- 出典データセット
- uspto-grants-1997_12
- 特許番号
- US05703100
関連ノート
読み込み中…